CLINICAL_TRIALS
trial_result
· 2017-07-11
Clinical Trial Update: Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations [Phase 4]
Summary
Phase 4 trial update evaluating the effects of indacaterol in symptomatic chronic obstructive pulmonary disease patients at low risk of exacerbations; results w…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-07-11